PET scan study for memory decline with head injury or Alzheimer's risk
Part of Brain & nervous system, Injuries & trauma, Mental health clinical trials.
This trial uses a special PET scan tracer to see if it can predict who will get worse over time. It is for people with mild memory or thinking problems that may be linked to past head injuries or early Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have mild cognitive impairment (minor memory or thinking problems) that might be due to past head injuries or early Alzheimer's disease.
- You need a study partner (like a family member or friend) who sees you at least 3–4 times a week and can come to visits with you.
- You must be willing to have a PET scan and come back for checkups at 1 and 2 years.
- You cannot have certain other medical conditions, such as a recent stroke, seizures, or uncontrolled depression.
- You must not be pregnant, breastfeeding, or have any metal implants that are not safe for MRI.
- You cannot have taken certain Alzheimer's medications or been in another drug trial within the past few months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This extension study looks for predictors—measurable clues—linked to memory changes in older adults who feel their memory is worsening. You may be asked to have an amyloid PET scan, which can help researchers understand what might be driving memory concerns.
This early-phase study tests a new PET scan tracer that targets a brain chemical transport system involved in dementia. It aims to see if the tracer can safely and clearly show brain changes, which could help future dementia diagnosis or tracking.
This trial tests a new PET imaging agent (18F-XTR006) to see how well it shows brain changes related to Alzheimer's disease. It may help diagnose MCI (mild cognitive impairment) or Alzheimer's earlier by comparing images in healthy people and those with memory problems.
This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.
This study uses a PET brain scan with a small injected tracer to look for “tau” protein changes linked to Alzheimer’s disease. It may help researchers better understand how tau appears in people who are cognitively normal or have mild dementia.
Hear when a new Chronic Traumatic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.